Want to join the conversation?
$CELG Form 4: Michael Friedman, Director of Celgene Corporation exercised 733 stock options, one-third of RSUs are granted to reporting person on July 1, 2014 vested and settled for shares of the company's common stock on July 1, 2015. Post transaction, he now owns zero shares.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.